WESTON, Mass., Sept. 23, 2024 (GLOBE NEWSWIRE) — ModeX Therapeutics Inc., an OPKO Health, Inc. (NASDAQ: OPK) company, today announced the appointment of Giovanni ...
WESTON, Mass., June 09, 2025 (GLOBE NEWSWIRE) -- ModeX Therapeutics Inc., an OPKO Health company (NASDAQ: OPK), today announced the creation of a Scientific Advisory Board to provide counsel and ...
(RTTNews) - Wednesday, Regeneron Pharmaceuticals, Inc. (REGN) and ModeX Therapeutics Inc., an OPKO Health company (OPK) entered into a license and collaboration agreement to discover and develop ...
WESTON, Mass. - ModeX Therapeutics Inc., a subsidiary of OPKO Health (NASDAQ:OPK), has established a Scientific Advisory Board to guide the development of its immunology and oncology portfolio, which ...
The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...
The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...
ModeX Therapeutics Inc., an OPKO Health company, announced the creation of a Scientific Advisory Board to provide counsel and insight into the development of ModeX’s immunology and oncology-focused ...
Will provide expertise across ModeX’s portfolio of next generation multispecific antibodies for complex diseases involving the immune system, including cancer ModeX’s promising immunology pipeline ...
Will provide expertise across ModeX's portfolio of next generation multispecific antibodies for complex diseases involving the immune system, including cancer ModeX's promising immunology pipeline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback